SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-034814
Filing Date
2022-12-08
Accepted
2022-12-08 07:00:19
Documents
13
Period of Report
2022-12-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37873
2 ex99-1.htm EX-99.1 6273
  Complete submission text file 0001493152-22-034814.txt   217600

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bixt-20221202.xsd EX-101.SCH 3297
4 XBRL LABEL FILE bixt-20221202_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bixt-20221202_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3485
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 221451370
SIC: 2834 Pharmaceutical Preparations